2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Trauma
Concurrent

Biomarkers: Late-Breaking Technology That Can Change How We Manage Critically Ill Trauma Patients

Tuesday, March 24, 2026
9:45 AM - 10:45 AM Central Time
Location: W184

Biomarkers in critical care have been a hot topic over the years. Biomarker research for critically ill trauma patients has finally shown validity and will become more mainstream during the next few years. This session will delve into the latest advancements in blood biomarkers pertinent to critically ill trauma patients. Speakers will focus on groundbreaking research and clinical applications in three areas: traumatic brain injury, kidney, and nutrition/metabolic function and outcomes.

Learning Objectives:

  • Interpret the clinical significance of blood biomarkers in determining severity and outcomes in patients with traumatic brain injury
  • Evaluate the role of emerging blood biomarkers for stratifying patient risk and guiding precision-based interventions in patients with acute kidney disease
  • Discuss biomarker-driven metabolic assessments, including inflammatory and oxidative stress markers, for optimizing personalized nutritional interventions and improving outcomes

Presentations:

  • 9:50 AM - 10:05 AM Central Time
    Decoding TBI: Blood Biomarkers Transforming Traumatic Brain Injury Diagnosis and Management

    Sarah Monchar, Select Member HP

  • 10:05 AM - 10:20 AM Central Time
    Metabolic Markers: Revolutionizing Nutritional Strategies in the Metabolic Derangements of Trauma Patients

    Paul Wischmeyer, MD, EDIC, FASPEN (he/him/his) – Duke University School of Medicine

  • 10:20 AM - 10:35 AM Central Time
    Landscape of Kidney Biomarker Use in Critically Ill Patients

    Sandra Kane-Gill, MSc, PharmD, FCCP (she/her/hers) – University of Pittsburgh